November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.
August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.
April 4, 2024
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research annual meeting 2024, April 5-10 in San Diego, California.
January 24, 2024
University of Cincinnati James L. Winkle College of Pharmacy alumna Samar Alanazi leaves a lasting legacy and made groundbreaking breast cancer research discoveries while battling her own cancer diagnosis since 2014.
April 30, 2025
Researchers led by the University of Cincinnati’s Anna Kruyer and the University of Houston’s Demetrio Labate have published research in the journal Science Advances applying object recognition technology to track changes in brain cell structure and provide new insights into how the brain responds to heroin use, withdrawal and relapse.
April 25, 2025
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2025 in Chicago.
May 21, 2025
New research led by the University of Cincinnati’s Nalinikanth Kotagiri recently published in the journal Gut Microbes demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.
March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 16, 2023
The University of Cincinnati's Bingfang Yan's research team has received a $2.5 million National Institutes of Health grant to answer the question of how FDA-approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.